Three-dimensional-software developer Voxar of Edinburgh, Scotland, is scheduled to showcase version 4.1 of its flagship 3-D software, Voxar 3D, and version 2.2 of its Voxar Colonscreen at the upcoming European Congress of Radiology in Vienna, March 7-11.
The 4.1 iteration of Voxar 3D features capabilities to review, edit, and window-level in any plane from any multiplanar reformat (MPR) or slab, prior to capture of the image. In addition, misaligned scans, or anatomy that does not align with scan planes, can be corrected to a standard orientation prior to reading.
The firm has also improved the product’s curved MPR features, as well as its 3-D color volume-rendered slab features. New features enable bone removal from the image, permitting 3-D angiography, and a rapid DICOM transfer capability, Live Images, which enables the technologist to move the image to from postprocessing to the physician.
Voxar’s latest iteration of its CT colonography product, Voxar Colonscreen, version 2.2, features streamlined reporting and user-interface improvements, faster loading of large datasets, and improvements to image quality for small-volume visualization, according to the company.
By AuntMinnie.com staff writersMarch 4, 2003
Related Reading
Voxar expands U.S. presence with new Boston office, December 4, 2002
Voxar debuts Calscreen 2.1, July 9, 2002
NovaRad inks 3-D deal with Voxar, June 28, 2002
Voxar appoints new chairman, May 29, 2002
Voxar showcases Plug n View 3D 2.2 , May 3, 2002
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
